Latest Shareholder Approvals News

Encounter Resources has completed the first tranche of its $25 million share placement, raising approximately $24.5 million to advance its mineral exploration projects. The second tranche, involving shares to a company director, awaits shareholder approval.

Scout Security has entered a binding agreement to acquire New York-based Roo Inc in a merger of equals, combining their complementary home security technologies and customer bases to create a scalable global security-as-a-service platform.

Mineral Commodities Ltd has terminated its sale agreement with Norge Mineraler for the Skaland Graphite Project due to non-payment and is now negotiating a new deal with LNS Holding AS.

Middle Island Resources has completed its acquisition of Konstantin Resources, issuing over 750 million new securities following shareholder approval. This marks a significant expansion in Middle Island's portfolio and capital structure.

Arafura Rare Earths secures an ASX waiver allowing eligible shareholders to vote on its upcoming Share Purchase Plan, ensuring broader participation in a key capital raising step.

Tryptamine Therapeutics has raised $6.1 million to fast-track clinical development of its IV-infused psilocin drug TRP-8803, targeting binge eating disorder and other neuropsychiatric conditions.

TPG Telecom has announced a substantial special dividend and capital reduction totaling approximately AUD 3 billion, pending shareholder approval at the upcoming EGM.

Olympio Metals has raised $1.25 million to fund further exploration at its promising Bousquet Gold Project, following a maiden drilling program that intersected significant gold mineralisation in over 85% of holes.

Kingsland Minerals has successfully closed an oversubscribed Share Purchase Plan, raising A$543,000 to advance its Leliyn Graphite Project and exploration efforts.

Infinity Mining has raised A$1 million through a discounted placement to accelerate exploration in Victoria and advance its innovative mineral extraction partnership at the Cangai Project.

TrivarX Limited has exercised its option to acquire the innovative Stabl-Im brain imaging technology, aiming to revolutionize early detection of brain tumours pending shareholder approval.

BlueScope has appointed Tania Archibald as its new Managing Director and CEO, succeeding Mark Vassella who retires after eight years. Archibald’s extensive internal experience positions her to lead the company’s next strategic phase.